Zag Bio Launches with $80 Million Financing to Pioneer Thymus-Targeted Therapies for Autoimmune Diseases

Discovery and development of the first systemic therapeutics to deliver self-antigens directly to the thymus to harness the body’s natural mechanis...

October 29, 2025 | Wednesday | News
GSK and Empirico Enter Exclusive Licensing Agreement for Novel siRNA Candidate EMP-012 in COPD

siRNA candidate EMP-012 in phase I for treatment of COPD EMP-012 targets a distinct inflammatory pathway with enhanced potency and longer dose int...

October 29, 2025 | Wednesday | News
Catalent Introduces New Corporate Brand to Champion “Missions That Matter” Across Global Healthcare

Reflects Catalent’s unparalleled service and best-in-class capabilities across the pharmaceutical, biotech and consumer health categories Rein...

October 29, 2025 | Wednesday | News
Fibronostics Acquires Stone Clinical Laboratories to Expand U.S. Operations and Advance Non-Invasive Diagnostics for Metabolic and Liver Diseases

Acquisition expands U.S. lab operations and accelerates innovation in non-invasive diagnostics for metabolic and liver diseases. Fibronostics, a global ...

October 28, 2025 | Tuesday | News
Neurotronic Presents First Clinical Results of Neuviant™ Multi-Organ Denervation in Type 2 Diabetes and Hypertension at TCT 2025

Neurotronic, Inc., a developer of multi-organ denervation to treat complex cardiovascular and metabolic disease, announced that the first clinical outcom...

October 28, 2025 | Tuesday | News
Jupiter Neurosciences Secures Up to $20 Million in Flexible Financing from Yorkville Advisors to Advance Parkinson’s Trial and Nugevia™ Expansion

Financing designed to support Phase 2 Parkinson’s trial and accelerate Nugevia™ product line growth Jupiter Neurosciences, Inc , a clinical...

October 28, 2025 | Tuesday | News
Pulse Biosciences Announces First U.S. Surgical Treatment Using Nanosecond PFA Clamp for Atrial Fibrillation

First U.S. Surgical Treatments with PFA Clamp for Patients with Atrial Fibrillation During Concomitant Surgical Procedure -Pulse Biosciences, ...

October 27, 2025 | Monday | News
Aesculap Launches New Irrigating Specialty Non-Stick Disposable Bipolar Forceps in the U.S.

Aesculap, Inc., a leader in surgical innovation, announced the launch of its new Irrigating Specialty Non-Stick Disposable Bipolar Forceps to the U.S. ma...

October 21, 2025 | Tuesday | News
Building Biopharma Resilience — Cytiva’s Pierre-Alain Ruffieux on Balancing Progress and Preparedness

Resilience is no longer a corporate slogan — it’s the new currency of survival in biopharma. As the sector races between scientific breakthroug...

October 20, 2025 | Monday | Interaction
Kezar Life Sciences Initiates Strategic Review Following FDA Setback on Autoimmune Hepatitis Trial

-Kezar Life Sciences, Inc. a clinical-stage biotechnology company developing novel small molecule therapeutics to treat unmet needs in immune-mediated di...

October 17, 2025 | Friday | News
Roquette Opens Health & Pharma Solutions Innovation Centre in Brazil to Drive Drug Delivery Innovation and Inspire Future Scientists

Roquette, a global leader in plant-based ingredients and pharmaceutical excipients for health, nutrition and bio industrial markets,  celebrates the...

October 17, 2025 | Friday | News
French Biotech EVerZom Raises €10 Million to Launch First Clinical Trial of Exosome Therapy EVerGel™

Through this funding round, the company will initiate the clinical development of its first therapeutic candidate, EVerGel, in 2026, and will enhance its...

October 16, 2025 | Thursday | News
NuCana’s NUC-3373 Plus Pembrolizumab Shows Durable Responses in Heavily Pre-Treated Cancer Patients

NUC-3373 Plus Pembrolizumab Continues to Show Favorable Efficacy and Safety Profile in Heavily Pre-treated Patients Latest Data Cut-Off Shows Patient wi...

October 16, 2025 | Thursday | News
Corventum Secures FDA Clearance for IND of CVT-130 to Prevent Chemotherapy-Induced Cardiotoxicity

-Corventum, Inc., a new medicines company advancing novel therapies to make existing cancer treatments safer and more effective,  announced the clea...

October 15, 2025 | Wednesday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close